Pfizer to spend $11.6B on migraine treatment maker Biohaven

Pfizer is starting to put its COVID-19 cash influx to use by spending $11.6 billion to venture deeper into a new treatment area
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news